PowderClinical Overview
Omeprazole (20mg) with Sodium Bicarbonate Powder for Oral Suspension is an immediate-release proton pump inhibitor formulation. Sodium bicarbonate neutralizes gastric acid instantly, elevating intragastric pH and protecting unprotected omeprazole from acid degradation during transit to the duodenum, allowing rapid absorption without enteric coating. Indicated for acute heartburn relief, active duodenal/gastric ulcers, GERD, and prevention of upper GI bleeding in critically ill patients.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
Empty packet contents into a small cup containing 15-30 mL of water. Stir well and drink immediately. Refill cup with water and drink to ensure the complete dose is consumed. Take on an empty stomach at least 1 hour before a meal. Do not mix with liquids other than water.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Headache, nausea, diarrhea, abdominal pain, flatulence, belching (due to bicarbonate). Rare/Severe: Hypernatremia, metabolic alkalosis, hypomagnesemia, and C. difficile diarrhea.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Contains significant sodium (sodium bicarbonate buffer); use with caution in patients on sodium-restricted diets, hypertension, heart failure, or renal impairment.
Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or gastrointestinal treatment recommendations. Always consult a registered gastroenterologist or qualified medical practitioner before initiating, altering, or discontinuing any gastrointestinal medication or digestive therapy.
Omeprazole 20mg + Domperidone 10mg Capsules
Omeprazole (20mg gastro-resistant) and Domperidone (10mg/30mg sustained-release) is a cornerstone fixed-dose PPI and prokinetic combination on the WHO Model List framework. Omeprazole irreversibly suppresses gastric acid secretion by inhibiting parietal cell H+/K+-ATPase. Domperidone blocks peripheral dopamine D2 receptors in the chemoreceptor trigger zone (CTZ) and gastrointestinal tract, stimulating gastric motility and preventing acid reflux. Indicated for gastroesophageal reflux disease, non-ulcer dyspepsia, and peptic ulcer disease accompanied by nausea, fullness, or vomiting.
Omeprazole Gastro-resistant 20mg + Domperidone Sustained Release 30mg Capsules
Omeprazole (20mg gastro-resistant) and Domperidone (10mg/30mg sustained-release) is a cornerstone fixed-dose PPI and prokinetic combination on the WHO Model List framework. Omeprazole irreversibly suppresses gastric acid secretion by inhibiting parietal cell H+/K+-ATPase. Domperidone blocks peripheral dopamine D2 receptors in the chemoreceptor trigger zone (CTZ) and gastrointestinal tract, stimulating gastric motility and preventing acid reflux. Indicated for gastroesophageal reflux disease, non-ulcer dyspepsia, and peptic ulcer disease accompanied by nausea, fullness, or vomiting.